Stock listing
NYSE:TEVA Teva Pharmaceutical Industries Limited Stock
US listing (NYSE) of Teva Pharmaceutical Industries Limited · home listing TASE:TEVA
Follow Teva Pharmaceutical Industries Limited into a list and get an email when it puts out news.
Share price · NYSE:TEVA
$40.39 USD +0.98 (+2.5%)
Close on Oct 27, 2026
- Day range
- $39.71 – $40.86 USDOct 27, 2026
- Volume
- 5.98M sharesOct 27, 2026
- Market cap
- $47.11B USDAt the close on Oct 27, 2026 · price × 1.17B shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TASE:TEVA · Home | 12,720 ILA (agorot) | +110 (+0.9%) | 1,308,939 | 12,380 | 12,790 | 12,380 | 12,610 | Close on Oct 29, 2026 |
| NYSE:TEVA | $40.39 USD | +0.98 (+2.5%) | 5,978,834 | $39.71 | $40.86 | $39.71 | $39.41 | Close on Oct 27, 2026 |
| B3:T1EV34 | 99.20 BRL | -5.52 (-5.3%) | 71 | 99.50 | 99.50 | 98.40 | 104.72 | Close on Oct 23, 2026 |
- Ticker
- NYSE:TEVA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Oct 1, 2026
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
Latest earnings call · Jul 29, 2026
Teva Pharmaceutical Industries (TASE:TEVA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 9, 2026
Corporate Update (October 2026)
Corporate update · 15 slides
Calls
Upcoming
Teva Pharmaceutical Industries (TASE:TEVA) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Register
Replays
Teva Pharmaceutical Industries (TASE:TEVA) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 8:00 AM ET
Watch TranscriptTeva Pharmaceutical Industries (TASE:TEVA) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 8:00 AM ET
Watch TranscriptTeva Pharmaceutical Industries (TASE:TEVA) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Senior notes
Sep 10, 2026
Announced: about US$4.9B
Use of proceeds: Redeem certain existing notes, pay related fees and expenses, and general corporate purposes including repaying outstanding debt
Decks
Corporate Update (October 2026)
Corporate update · 15 slides · Oct 9, 2026
IL-15 Celiac Disease Phase 2a Topline Results - Conference Call (September 2026)
Conference · 23 slides · Sep 2, 2026
Q2 2026 Earnings Presentation
Earnings · 74 slides · Jul 29, 2026
Technical Presentation (July 2026)
Technical · 19 slides · Jul 7, 2026
Teva Pharmaceutical Industries Limited on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 47 in the last 12 months · 91 in all · newest Oct 1, 2026 · oldest 2025
- Calls
- 14 calls with a replay · 14 with a transcript · latest Jul 29, 2026
- Decks
- 138 decks · latest Oct 9, 2026
Where Teva Pharmaceutical Industries Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TASE:TEVA · Home listing | TASE | Israel | ILA |
| NYSE:TEVA · This page | NYSE | United States | USD |
| gettex:TEV | gettex | Germany | EUR |
| Frankfurt:TEV | Frankfurt | Germany | EUR |
| Tradegate:TEV | Tradegate | Germany | EUR |
| BOATS:TEVA | BOATS | United States | USD |
| OTC:TEVJF | OTC | United States | USD |
| LS Exchange:883035 | LS Exchange | Germany | EUR |
| B3:T1EV34 | B3 | Brazil | BRL |
| BMV:TEVAN | BMV | Mexico | MXN |
| VIE:TEVA | Vienna | Austria | EUR |
| BX Swiss:TEV | BX Swiss | Switzerland | CHF |
| LSIN:0LER | LSIN | United Kingdom | USD |
| Stuttgart:TEV | Stuttgart | Germany | EUR |
| Hanover:TEV | Hanover | Germany | EUR |
| Lang & Schwarz:883035 | Lang & Schwarz | Germany | EUR |
| BSESOF:TEV | BSESOF | Bulgaria | EUR |
| Dusseldorf:TEV | Dusseldorf | Germany | EUR |
| Hamburg:TEV | Hamburg | Germany | EUR |
| Munich:TEV | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Teva Pharmaceutical Industries Limited.